Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells

Human Cell

Volumn 20, Issue 4, 2007, Pages 100-106

  Miyata, Shiro ^a,b   Fukushima, Tsuyoshi ^b   Kohama, Kazuyo ^b   Tanaka, Hiroyuki ^b   Takeshima, Hideo ^a   Kataoka, Hiroaki ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Glioblastoma; HAI 1; Invasion; Kunitz domain; Protease inhibitor

Indexed keywords

COLLAGEN TYPE 4; FIBRIN; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID MOTIFS; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; PROTEIN STRUCTURE, TERTIARY; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE PROTEINASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 35448988591     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2007.00035.x     Document Type: Article

References (32)

1. Shimomura T, Denda K, Kitamura A et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 1997 272 : 6370 6.
2. Kataoka H, Itoh H, Hamasuna R, Meng JY, Koono M. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas. roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Hum Cell 2001 14 : 83 93.
3. Kataoka H, Miyata S, Uchinokura S, Itoh H. Roles of hepatocyte growth factor (HGF) activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metast Rev 2003 22 : 223 36.
4. Tanaka H, Nagaike H, Takeda N et al. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 2005 25 : 5687 98.
5. Fan B, Brennan J, Grant D, Peale F, Rangell L, Kirchhofer D. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the development placental labyrinth. Dev Biol 2007 303 : 222 30.
6. Szabo R, Molinolo A, List K, Bugge TH. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 2007 26 : 1546 56.
7. Kataoka H, Shimomura T, Kawaguchi T et al. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 2000 275 : 40453 62.
8. Lin CY, Anders J, Johnson M, Dickson RB. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 1999 274 : 18237 42.
9. Kircihhofer D, Peek M, Lipari MT, Billeci K, Fan B, Moran P. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2. FEBS Lett 2005 579 : 1945 50.
10. Fan B, Wu TD, Li W, Kirchhofer D. Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J Biol Chem 2005 280 : 34513 20.
11. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993 268 : 10024 8.
12. Lee SL, Dickson RB, Lin CY. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 2000 275 : 36720 5.
13. List K, Szabo R, Molinolo A et al. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 2005 19 : 1934 50.
14. Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 2004 6 : 185 95.
15. Nagaike K, Kohama K, Uchiyama S et al. Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front. Cancer Sci 2004 95 : 728 35.
16. Knudsen BS, Lucas JM, Fazli L et al. Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate. Am J Pathol 2005 167 : 255 66.
17. Miyata S, Uchinokura S, Fukushima T et al. Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo. Cancer Lett 2005 227 : 83 93.
18. Moriyama T, Kataoka H, Tsubouchi H, Koono M. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 1995 372 : 78 82.
19. Nabeshima K, Shimao Y, Sato S et al. Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study. Histopathology 1997 31 : 436 43.
20. Moriyama T, Kataoka H, Kawano H et al. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett 1998 124 : 149 55.
21. Nuki Y, Uchinokura S, Miyata S et al. Establishment and characterization of a new human glioblastoma cell line, NYGM. Hum Cell 2004 17 : 145 50.
22. Moriyama T, Kataoka H, Seguchi K, Tsubouchi H, Koono M. Effects of hepatocyte growth factor (HGF) on human glioma cells in vivo: HGF acts as a motility factor in glioma cells. Int J Cancer 1996 66 : 678 85.
23. Uchinokura S, Miyata S, Fukushima T et al. Roles of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. Int J Cancer 2006 118 : 583 92.
24. Kataoka H, Itoh H, Nuki Y et al. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator. Biochem Biophys Res Commun 2002 290 : 1096 100.
25. Denda K, Shimomura T, Kawaguchi T, Miyazawa K, Kitamura N. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem 2002 277 : 14053 9.
26. Kirchhofer D, Peek M, Li W et al. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem 2003 278 : 36341 9.
27. Kataoka H, Itoh H, Koono M. Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol Int 2002 52 : 89 102.
28. Kataoka H, Suganuma T, Shimomura T et al. Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem 1999 47 : 673 82.
29. Generali D, Fox SB, Berruti A et al. Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer. Clin Cancer Res 2007 13 : 550 8.
30. Kobayashi H, Suzuki M, Tanaka Y, Kaneyama N, Terao T. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade. J Biol Chem 2003 278 : 7790 9.
31. Kobayashi H, Yagyu T, Inagaki K et al. Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer. Cancer 2004 100 : 869 77.
32. Yagyu T, Kobayashi H, Matsuzaki H et al. Enhanced spontaneous metastasis in bikunin-deficient mice. Int J Cancer 2006 118 : 2322 8.